Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanoma. (Q52859139)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2016

Language	Label	Description	Also known as
English	Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanoma.	scientific article published in June 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/27246630

Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/27246630

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/27246630

4

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/27246630

2

object named as

Gerold Schuler

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/27246630

1

object named as

Ugur Uslu

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/27246630

publication date

1 June 2016

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/27246630

Experimental Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/27246630

25

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/27246630

11

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/27246630

872-879

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/27246630

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies.

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall Street

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

T-cell antigen receptor genes and T-cell recognition

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

The emergence of T-bodies/CAR T cells

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Engineered T cells for cancer treatment

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Genetic modification of T cells

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

T cell-based gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Genetically modified T cells for the treatment of malignant disease

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Treating cancer with genetically engineered T cells

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Antibody-modified T cells: CARs take the front seat for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

A fast and robust method to clone and functionally validate T-cell receptors

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone.

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Treatment of advanced leukemia in mice with mRNA engineered T cells

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells.

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Biological and clinical developments in melanoma vaccines

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Antigen-processing machinery breakdown and tumor growth

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Generation of CD8(+) T cells expressing two additional T-cell receptors (TETARs) for personalised melanoma therapy.

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

The NG2 chondroitin sulfate proteoglycan: role in malignant progression of human brain tumours

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Unexpected expression of the 250 kD melanoma-associated antigen in human sarcoma cells.

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Antitumor activity of dual-specific T cells and influenza virus

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Engineered T cells for cancer therapy.

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

T cells as a self-referential, sensory organ

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Molecular architecture of the αβ T cell receptor-CD3 complex

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Selected murine residues endow human TCR with enhanced tumor recognition

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability

1 reference

https://api.crossref.org/works/10.1111%2FEXD.13095

21 January 2018

Identifiers

10.1111/EXD.13095

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/27246630

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/27246630

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52859139&oldid=1752916688"